Hohage H - Search Results

1

Cyclosporine does not influence serum cholesterol in kidney transplant recipients.

Matzkies FK, Keuthage W, Kobelt V, Hillebrand U, Gerhardt U, Suwelack B, Hohage H. Matzkies FK, et al. Among authors: hohage h. Transplant Proc. 2002 Aug;34(5):1795-6. doi: 10.1016/s0041-1345(02)03081-6. Transplant Proc. 2002. PMID: 12176580 No abstract available.

2

Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.

Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H. Suwelack B, et al. Among authors: hohage h. Transpl Int. 2003 May;16(5):313-20. doi: 10.1007/s00147-002-0514-x. Epub 2003 Feb 20. Transpl Int. 2003. PMID: 12759722 Clinical Trial.

3

Cyclosporine A modulates baroreceptor function in kidney transplant recipients.

Gerhardt U, Riedasch M, Hohage H. Gerhardt U, et al. Among authors: hohage h. Int J Cardiol. 1999 Feb 28;68(2):203-8. doi: 10.1016/s0167-5273(98)00368-4. Int J Cardiol. 1999. PMID: 10189009

4

Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients.

Gerhardt U, Grosse Hüttmann M, Hohage H. Gerhardt U, et al. Among authors: hohage h. Clin Transplant. 1999 Oct;13(5):375-9. doi: 10.1034/j.1399-0012.1999.130502.x. Clin Transplant. 1999. PMID: 10515217

5

The beneficial effects of calcium channel blockers on long-term kidney transplant survival are independent of blood-pressure reduction.

Mehrens T, Thiele S, Suwelack B, Kempkes M, Hohage H. Mehrens T, et al. Among authors: hohage h. Clin Transplant. 2000 Jun;14(3):257-61. doi: 10.1034/j.1399-0012.2000.140313.x. Clin Transplant. 2000. PMID: 10831086

6

High QT dispersion in tacrolimus-treated kidney transplant recipients.

Gerhardt U, Suwelack B, Pawolka A, Hohage H. Gerhardt U, et al. Among authors: hohage h. Transplant Proc. 2001 May;33(3):2148-50. doi: 10.1016/s0041-1345(01)01924-8. Transplant Proc. 2001. PMID: 11377482 No abstract available.

7

Cyclosporine A metabolite AM19 as a potential biomarker in urine for CSA nephropathy.

Kempkes-Koch M, Fobker M, Erren M, August C, Gerhardt U, Suwelack B, Hohage H. Kempkes-Koch M, et al. Among authors: hohage h. Transplant Proc. 2001 May;33(3):2167-9. doi: 10.1016/s0041-1345(01)01929-7. Transplant Proc. 2001. PMID: 11377489 No abstract available.

8

Structural vessel wall properties in kidney transplant recipients depend on hyperparathyroidism.

Suwelack B, Gerhardt U, Witta J, Hohage H. Suwelack B, et al. Among authors: hohage h. Transplant Proc. 2001 May;33(3):2310-2. doi: 10.1016/s0041-1345(01)02003-6. Transplant Proc. 2001. PMID: 11377541 No abstract available.

9

Total serum homocysteine does not influence carotid intimal media thickness.

Suwelack B, Gerhardt U, Witta J, Hohage H. Suwelack B, et al. Among authors: hohage h. Transplant Proc. 2001 May;33(3):2381-3. doi: 10.1016/s0041-1345(01)02030-9. Transplant Proc. 2001. PMID: 11377568 Clinical Trial. No abstract available.

10

Influence of antihypertensive drugs on renal microcirculation and renal hemodynamics in cyclosporine A-treated rats.

Hillebrand U, Kobelt V, vOphoven M, Suwelack B, Matzkies F, Gerhardt U, Sindermann J, Hohage H. Hillebrand U, et al. Among authors: hohage h. Transplant Proc. 2002 Aug;34(5):1383-4. doi: 10.1016/s0041-1345(02)03068-3. Transplant Proc. 2002. PMID: 12176406 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters